Evidence map›Paper›PMID 38786681›Full record

ArticleJournal of fungi (Basel, Switzerland)2024

Juan Camilo Hernández-Pabón, Bryan Tabares, Óscar Gil, Carlos Lugo-Sánchez, Aldair Santana, Alfonso Barón, Carolina Firacative

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Biofilm-related characteristics ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Occurrence of pathogenic yeastF1000Research · 2024
    Article
  12. Antifungal susceptibility, molecular epidemiology, and clinical risk factors ofFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juan Camilo Hernández-PabónGroup MICROS Research Incubator, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia.ORCID 0000-0002-6228-0672
Bryan TabaresUnidad de Extensión Hospitalaria, Hospital Universitario Mayor Méderi, Bogota 111411, Colombia.
Óscar GilGroup MICROS Research Incubator, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia.
Carlos Lugo-SánchezGroup MICROS Research Incubator, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia.
Aldair SantanaClinical Laboratory and Transfusion Service, Hospital Universitario Mayor Méderi, Bogota 111411, Colombia.
Alfonso BarónDepartment of Medical Clinics, Hospital Universitario Mayor Méderi, Bogota 111411, Colombia.
Carolina FiracativeStudies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia.ORCID 0000-0001-7547-5172

Funding

Centro de Investigaciones de Méderi - CIMED B-024-2021
6 · The paper itself

Abstract

Increasingly common and associated with healthcare settings,

Indexed as

antifungal drug resistanceCandidaColombiaepidemiologyhealthcare-associated infectionsinvasive fungal infections

Identifiers

PMID38786681
PMCPMC11122357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.